Literature DB >> 10399619

How the brain anticipates an attack: a study of neurophysiological periodicity in migraine.

M Siniatchkin1, W D Gerber, P Kropp, A Vein.   

Abstract

We investigated cortical excitability and the pattern of arousal in migraine patients using contingent negative variation (CNV) and EEG power spectrum analysis performed before and after a migraine attack. Twenty females suffering from migraine without aura and 12 healthy controls were enrolled in the study. In the group of patients, the CNV, EEG power spectrum and hemispheric asymmetry analyses were performed 1-4 days before the first day of an attack and 4 days following the last day with migraine. The recordings in healthy subjects were carried out on a day chosen by the participants. The comparisons were made using non-parametric procedures. After an attack no difference was found between patients and controls in EEG power spectrum, hemispheric asymmetry or CNV components (with the exception of the beta 1 power, which was more pronounced in patients). Before an attack, however, a significant increase in the power of delta and theta frequency bands, in the alpha asymmetry, and in early CNV amplitude were observed. The patients differed from controls both in the extent of cortical excitability and in the arousal pattern found. In such a way migraine is characterized by periodic CNV and EEG power spectrum changes during the pain-free interval. The abnormalities in cortical excitability and arousal were only observed before an attack, and could be used to predict the next migraine episode. We assume that these changes reflect the increased susceptibility of the migrainous brain to precipitating factors and the neurophysiological readiness to generate an attack. The time duration since the last attack must be taken into account when performing studies in the field of migraine research.

Entities:  

Mesh:

Year:  1999        PMID: 10399619

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  7 in total

1.  No deficit in neurocortical information processing in patients with cleft lip and palate.

Authors:  Volker Gassling; Kai Receveur; Uwe Niederberger; Bernd Koos; Claudia Helene Overath; Falk Birkenfeld; Jörg Wiltfang; Wolf-Dieter Gerber; Michael Siniatchkin
Journal:  Clin Oral Investig       Date:  2015-04-02       Impact factor: 3.573

2.  Developmental changes of the contingent negative variation in migraine and healthy children.

Authors:  Michael Siniatchkin; Anne Jonas; Huelya Baki; Andreas van Baalen; Wolf-Dieter Gerber; Ulrich Stephani
Journal:  J Headache Pain       Date:  2009-12-15       Impact factor: 7.277

3.  Interictal quantitative EEG in migraine: a blinded controlled study.

Authors:  Marte Helene Bjørk; Lars J Stovner; Morten Engstrøm; Marit Stjern; Knut Hagen; Trond Sand
Journal:  J Headache Pain       Date:  2009-08-25       Impact factor: 7.277

4.  Resting-state EEG power and coherence vary between migraine phases.

Authors:  Zehong Cao; Chin-Teng Lin; Chun-Hsiang Chuang; Kuan-Lin Lai; Albert C Yang; Jong-Ling Fuh; Shuu-Jiun Wang
Journal:  J Headache Pain       Date:  2016-11-02       Impact factor: 7.277

5.  Current understanding of cortical structure and function in migraine.

Authors:  Else A Tolner; Shih-Pin Chen; Katharina Eikermann-Haerter
Journal:  Cephalalgia       Date:  2019-03-28       Impact factor: 6.292

6.  Dynamic brainstem and somatosensory cortical excitability during migraine cycles.

Authors:  Fu-Jung Hsiao; Wei-Ta Chen; Li-Ling Hope Pan; Hung-Yu Liu; Yen-Feng Wang; Shih-Pin Chen; Kuan-Lin Lai; Gianluca Coppola; Shuu-Jiun Wang
Journal:  J Headache Pain       Date:  2022-02-05       Impact factor: 7.277

7.  Does an aerobic endurance programme have an influence on information processing in migraineurs?

Authors:  Claudia H Overath; Stephanie Darabaneanu; Marie C Evers; Wolf-Dieter Gerber; Melanie Graf; Armin Keller; Uwe Niederberger; Henrik Schäl; Michael Siniatchkin; Burkhard Weisser
Journal:  J Headache Pain       Date:  2014-02-14       Impact factor: 7.277

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.